Session: Antimicrobial Resistance: Clinical and Basic Studies (IDWeek 2012 Meeting)

Friday, October 19, 2012: 12:30 PM-2:00 PM

Room: SDCC Poster Hall F-H

Topical Category: A. Antimicrobial Agents

Tracks: Investigative ID, Epidemiology and Infection Control

Presentations:

823

Biofilm production by multidrug resistant Acinetobacter Baumanni : and its impact on mortality rates and persistance of culture
Pamela Garciadiego-Fossas, MD ; Patricia Rodriguez-Zulueta, MD ; Carolina Del Rio-Avila ; Francisco Velez-Perez, MD ; Javier Garcia-Guerrero, MD ; Javier Reyes Mar ; Luis Fernandez-Maya ; Oscar Sosa-Hernandez, MD ; Cutberto Lopez-Espinoza, MD ; Rafael Valdez-Castro, MD ; Rafael Figueroa-Moreno, MD ; Sara Arroyo-Escalante ; David Moncada-Baron ; Rigoberto Hernandez-Castro, PHD ; Rafael Valdez, M.D.

824	Comparative Microbiology of Transcription Inhibitors Fidaxomicin and the Rifamycins in Clostridium difficile Farah Babakhani, PhD ; Jaime Seddon, BS ; Irina Artsimovitch, PhD ; Pam Sears, PhD

825	Phylogenetic analysis suggests putative resistance mechanisms in 27 fluoroquinolone monoresistant Mycobacterium tuberculosis isolates Brandon Eilertson, MD ; John Gibbons ; Fernanda Maruri ; Amondrea Blackman ; Antonis Rokas ; Timothy Sterling, MD

826	Genetic Basis for the Development of In Vivo Daptomycin Non-susceptibility in Vancomycin-Resistant E. faecium Theodoros Kelesidis, MD ; Romney M. Humphries, Ph.D. ; Ryan Tewhey, PhD ; George Sakoulas, MD Posters Abstract 35789 Kelesidis T.pdf (344.0 kB)

827

Characterization of carbapenem-resistant MDR Acinetobacter baumannii isolated from Philadelphia, PA (United States)
Bhaswati Sen, PhD ; Krista Lewandowski ; Nachiket Vaze ; Christopher Emery, MD ; Richard Hamilton, MD ; Ari Brooks, MD ; Suresh Joshi, MD, PhD

Posters

Sen et al- Ab poster IDSA 18Sep2012.pdf (631.9 kB)

828	Escherichia coli Sequence Type 131 (ST131) as an Emergent Multidrug-resistant Pathogen among US Veterans Aylin Colpan, MD ; Stephen Porter ; Brian Johnston, PhD ; Ruth Anway ; Lao Thao ; Michael A. Kuskowski, PhD ; James R. Johnson, MD

829	Tigecycline Activity Tested against Resistant Surveillance Subsets of Clinical Bacteria Collected Worldwide (2011) Helio Sader, MD, PhD ; Robert Flamm, PhD ; Ronald Jones, MD Posters IDWEEK12 Tigecycline R subsets 829.pdf (169.4 kB)

830

Ceftaroline and Comparator Potency among Nine USA Census Regions: Report from the 2011 Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program
Helio Sader, MD, PhD ; Robert Flamm, PhD ; Ronald Jones, MD

Posters

IDWEEK12 Ceftaroline by USA Census Region 830.pdf (132.5 kB)

831	Antimicrobial Activity of Ceftaroline Tested against Staphylococci with Reduced Susceptibility to Linezolid, Daptomycin or Vancomycin from USA Hospitals (2008�2011) Ronald Jones, MD ; Robert Flamm, PhD ; Helio Sader, MD, PhD Posters IDWEEK12 Ceftaroline R-Staph 831.pdf (111.8 kB)

832	Risk Factors for Efflux Pump Overexpression in Fluoroquinolone-Resistant Escherichia coli Jennifer Han, MD ; Irving Nachamkin, DrPH, MPH ; Pam Tolomeo, MPH ; Xiangqun Mao, PhD ; Warren Bilker, PhD ; Ebbing Lautenbach, MD, MPH, MScE Posters OST.pdf (231.9 kB)

833

Epidemiology of Carbapenem-Resistant Enterobacteriaceae in Canadian acute care hospitals in 2010/2011
Aboubakar Mounchili, DVM, MSc, PhD ; Laura Mateseje, B.Sc., M.Sc. ; Denise Gravel, BScN, MSc ; Michael Mulvey, PhD ; Elizabeth Bryce, MD FRCPC ; Diane Roscoe, MD FRCPC ; David Boyd, MSc ; Geoffrey Taylor, MD ; Joanne Embree, MD ; Kevin Katz, MD, CM, MSc ; Pamela Kibsey, MD, FRCPC ; Magdalena Kuhn, MD, FRCPC ; Eva Thomas, MD, PhD, FRCPC ; Nathalie Turgeon, MD ; Andrew E. Simor, MD, FRCPC ; The Canadian Nosocomial Infection Surveillance Program (CNISP)

834

Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) During Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
Megan Proulx, M.S. ; Sumanth Gandra, MD, MPH ; Samantha Palace ; Brenda Torres ; Susan Weir, MPH, PhD ; Tracy Stiles, M.S. ; Jon Goguen, PhD ; Richard Ellison III, MD

Posters

Slide1.JPG (1.2 MB)

835	Analysis of bla_KPC Expression and Porins, and Their Effect on Meropenem Susceptibility, in Clinical Isolates of E. coli Manisha Singh, MBBS ; Ezra Miller, MD ; Badiaa El-Imad, MD ; David Landman, MD ; John Quale, MD

836	Multidrug-resistant (MDR) Escherichia coli Sequence Type ST131 and other Gram-negative Rods (GNRs) in Stool Samples from Veterans Sudershan J Singh, MD ; Connie Clabots ; James R. Johnson, MD

837	Occurrence and Genetic Diversity of Oxa-51 like Genes among Multi Drug Resistant Acinetobacter in Saudi Arabia Dr. Mahmoud Aly, PhD. ; Hanan Balkhy, MD Posters IDWEEK2012 poster.pdf (4.1 MB)

838	Prevalence and genetic types of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Saudi Arabia Hanan Balkhy, MD ; Hamsa Tayeb ; Sameera Al Johani, MD ; Esam Al Yamani ; Aiman El-Saed, MD, PhD Posters IDweek_poster_ESBL - 2.pdf (227.6 kB)

839	Prevalence of Lamivudine Drug Resistance Among Hepatitis B Virus Untreated Patients Shaban R. Bagar Sr., PhD ; Suliman A. Gerd, PhD ; Fateh A. Nefroo, PhD

840	Linezolid Minimum Inhibitory Concentration (MIC) Creep in Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates at a Single Japanese Center Motoyasu Miyazaki ; Tohru Takata, MD, PhD ; Hidetoshi Kamimura

841	Evaluation for Mupirocin Resistance in Staphylococcus aureus isolates from Skin and Soft Tissue Infections in San Antonio, TX Katrin Mende, PhD ; Donna Hensley, MS ; Corey Falcon, MD ; Miriam Beckius, MPH ; Xin Yu, MS ; Deena Sutter, MD

842	Patterns in the Use of and Microbial Sensitivity to Imipenem After the Introduction of Ertapenem to Formulary: Evidence from a Multi-Center Hospital Network Denis Ishisaka, Pharm.D. ; Robert Romanelli, Ph.D. ; Trevor Jukes, B.S. ; Tim Schiro, Pharm.D.

843	Trends in susceptibility and ESBL-production for Klebsiella pneumoniae from intra-abdominal infections: SMART 2002-2011 Sibylle Lob, MD, MPH ; Samuel Bouchillon, MD ; Meredith Hackel, PhD, MPH ; Daryl Hoban, PhD ; Stephen Hawser, PhD ; Robert Badal, B.S.

844	Antimicrobial Susceptibility of Aerobic Gram-negative Pathogens of Intra-abdominal Infections in North and Latin America � SMART 2011 Robert Badal, B.S. ; Samuel Bouchillon, MD ; Sibylle Lob, MD, MPH ; Meredith Hackel, PhD, MPH ; Daryl Hoban, PhD ; Aaron Johnson, BS ; Stephen Hawser, PhD

845

Antimicrobial Activity of Ceftaroline Combined with Avibactam Tested Against Bacteria Collected from Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in USA Medical Centers (2011)
Helio Sader, MD, PhD ; Robert Flamm, PhD ; Ronald Jones, MD

Posters

IDWEEK12 CPT104 ABSSSI USA 845.pdf (124.0 kB)

846	Activity of the Novel Antimicrobial Combination Ceftolozane/Tazobactam, Tested Against Bacterial Isolates in USA Hospitals from Patients with Pneumonia (2011) Helio Sader, MD, PhD ; Robert Flamm, PhD ; Ronald Jones, MD Posters IDWEEK12 CXA201 USA Obj C 846.pdf (236.8 kB)

847	Validation of Two Vancomycin Nomograms in Patients 10 Years of Age and Older Jessica Gillon, PharmD ; James Cassat, MD, PhD ; M. Cecilia Di Pentima, MD, MPH

CME Credits:

See more of: Poster Abstract Session

<< Previous Session | Next Session >>